BenevolentAI

The company also works on biomedical research in women's health issues, rare human diseases, veterinary medicine, cosmeceuticals, nutraceuticals, agricultural technology and other fields of industry.

BenevolentAI is a bioinformatics startup company that develops and applies artificial intelligence and machine learning technology. It has developed Judgement Augmented Cognition System, an AI technology that enables the analysis of scientific information. The system supplies researchers and scientists with analytical tools in the exploration of human health and bioscience applications.

The company also works on biomedical research in women's health issues, rare human diseases, veterinary medicine, cosmeceuticals, nutraceuticals, agricultural technology and other fields of industry.

An AI-drug discovery company uniting human and machine intelligence to discover new ways to treat disease.

BenevolentAI is a bioinformatics startup company that develops and applies artificial intelligence and machine learning technology. It has developed Judgement Augmented Cognition System, an AI technology that enables the analysis of scientific information. The system supplies researchers and scientists with analytical tools in the exploration of human health and bioscience applications.

BenevolentAI combines advanced AI and machine learning with cutting edge science to decipher complex disease biology, generate novel insights and discover more effective medicines. Our unique computational R&D platform spans every step of the drug discovery process, powering an in-house pipeline of 25+ drug programmes from early discoverytowards clinical phases. With several successful collaborations with leading pharmaceutical organisations, we are also the only AI-drug discovery company with a clinically validated approach, having discovered a leading repurposed drug candidate for COVID-19.

The company also works on biomedical research in women's health issues, rare human diseases, veterinary medicine, cosmeceuticals, nutraceuticals, agricultural technology and other fields of industry.

BenevolentAI is headquartered in London with a research facility in Cambridge (UK) and a further office in New York, with a team of over 300 world-leading scientists and technologists progressing its mission to reinvent drug discovery and advance life-changing drugs through to the clinic.